mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.5 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.5 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.6 |
mRNA |
LY-2157299 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.6 |
mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.6 |